Overview
Michael Link is a Pediatric Hematologist Oncology provider in Palo Alto, California. Dr. Link is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Classical Hodgkin Lymphoma, and Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
His clinical research consists of co-authoring 35 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
725 Welch Rd, Palo Alto, CA 94304
Additional Areas of Focus
Dr. Link has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Lpch Medical Group Div Of Lucile
Lianna Marks is a Pediatric Hematologist Oncology provider in Palo Alto, California. Dr. Marks is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Acute Lymphoblastic Leukemia (ALL), and Langerhans Cell Histiocytosis.
Lpch Medical Group Div Of Lucile
Jay Balagtas is a Pediatric Hematologist Oncology provider in Palo Alto, California. Dr. Balagtas is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Hepatoblastoma, Acute Lymphoblastic Leukemia (ALL), Neuroblastoma, Ewing Sarcoma, and Bone Marrow Aspiration.
Allison Pribnow is a Pediatric Hematologist Oncology provider in Palo Alto, California. Dr. Pribnow is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Osteosarcoma, Ewing Sarcoma, Hodgkin Lymphoma, and Hepatoblastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hodgkin LymphomaDr. Link isDistinguished. Learn about Hodgkin Lymphoma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Classical Hodgkin LymphomaDr. Link isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Febrile NeutropeniaDr. Link isAdvanced. Learn about Febrile Neutropenia.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Experienced
- Childhood Acute Myeloid LeukemiaDr. Link isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Hemophagocytic LymphohistiocytosisDr. Link isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- HepatoblastomaDr. Link isExperienced. Learn about Hepatoblastoma.
- Hereditary NeuroblastomaDr. Link isExperienced. Learn about Hereditary Neuroblastoma.
- Langerhans Cell HistiocytosisDr. Link isExperienced. Learn about Langerhans Cell Histiocytosis.
- Marginal Zone Lymphoma (MZL)Dr. Link isExperienced. Learn about Marginal Zone Lymphoma (MZL).